APA (7th ed.) Citation

MK, N., SR, W., RJ, K., V, H., TA, B., CL, A., . . . SW, R. (2024). A Risk-Based Assessment for Determining the Pharmacokinetic Comparability Requirements of Biologic-Device Combination Products Administered by Subcutaneous Injection. The AAPS journal, 26(5), 100. https://doi.org/10.1208/s12248-024-00968-w

Chicago Style (17th ed.) Citation

MK, Nøhr, et al. "A Risk-Based Assessment for Determining the Pharmacokinetic Comparability Requirements of Biologic-Device Combination Products Administered by Subcutaneous Injection." The AAPS Journal 26, no. 5 (2024): 100. https://doi.org/10.1208/s12248-024-00968-w.

MLA (9th ed.) Citation

MK, Nøhr, et al. "A Risk-Based Assessment for Determining the Pharmacokinetic Comparability Requirements of Biologic-Device Combination Products Administered by Subcutaneous Injection." The AAPS Journal, vol. 26, no. 5, 2024, p. 100, https://doi.org/10.1208/s12248-024-00968-w.